Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
Other
Vivos Therapeutics Inc
Other Peer Comparison
Competitive Other Analysis
Latest Figures & CAGR of Competitors
Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
Other
-$1.1m
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Other
-$377.2m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-14%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Other
-$130m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-17%
|
|
CVS Health Corp
NYSE:CVS
|
Other
-$284m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
Cigna Corp
NYSE:CI
|
Other
-$505m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Other
$1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vivos Therapeutics Inc's Other?
Other
-1.1m
USD
Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Other amounts to -1.1m USD.
What is Vivos Therapeutics Inc's Other growth rate?
Other CAGR 5Y
-61%
The average annual Other growth rates for Vivos Therapeutics Inc have been -63% over the past three years , -61% over the past five years .